AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

Investors have poured billions of dollars into the "liquid biopsy" space for the early detection and tracking of cancer. Now ...

Rates of colon cancer among young people have been steadily rising over the past three decades, even as diagnoses among older people decline. A staggering 20% of colorectal cancer cases in 2019 ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

Detecting clinically insignificant cancer in the MRI-targeted biopsy group versus the systematic biopsy group had a relative risk of 0.43 (95 percent confidence interval, 0.32 to 0.57) and was ...

While battling cancer, country singer Joshua Ray Walker decided to share an update with fans inside the hospital.

Biopsy Devices Market size is valued at $2.71 Billion by 2030, and is anticipated to grow at a CAGR of 4% during the forecast ...

I’ve probably been more healthy this year with cancer than I’ve ever been,” the singer said in an Instagram video.

The Baltimore-based subsidiary of Japan's Sysmex said that the test is used to identify genetic mutations that are relevant for the treatment of various cancer types.